Concepedia

Anders Fuglsang

AF

10

Publications

461

Citations

10

H-Index

2003

Active since

Affiliations

University of Copenhagen(Current)

Novo Nordisk Foundation

Chr. Hansen (Denmark)

Novo Nordisk (Denmark)

MRC Laboratory of Molecular Biology

Anders Fuglsang is an author at University of Copenhagen specializing in medicine, molecular biology, and crispr.

ORCID

Top concepts

Publications per year

2003–2024

10

Publications

10

Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo

Anders Fuglsang, Fergal P. Rattray, Dan‐Eric Nilsson et al. · Antonie van Leeuwenhoek · 2003 · 152 citations

Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas

Nicholas Sofos, Mingxia Feng, Stefano Stella et al. · Molecular Cell · 2020 · 63 citations

, , +8

Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3

Arturo Carabias, Anders Fuglsang, Piero Temperini et al. · Nature Communications · 2021 · 46 citations · Full text

Retron-Eco1 assembles NAD+-hydrolyzing filaments that provide immunity against bacteriophages

Arturo Carabias, Sarah Camara-Wilpert, Mario Rodríguez Mestre et al. · Molecular Cell · 2024 · 46 citations · Full text

, , +1

Characterization of New Milk-derived Inhibitors of Angiotensin Converting Enzyme<i>In Vitro</i>and<i>In Vivo</i>

Anders Fuglsang, Dan‐Eric Nilsson, Niels C. Berg Nyborg · Journal of Enzyme Inhibition and Medicinal Chemistry · 2003 · 45 citations

, , +17

Rows per page

1–5 of 10